Stoke Therapeutics Inc buy BTIG Research
Start price
14.10.25
/
50%
€26.60
Target price
14.10.26
€33.70
Performance (%)
9.77%
Price
16.10.25
€29.20
Summary
This prediction is currently active. With a performance of 9.77%, the BUY prediction by BTIG_Research for Stoke Therapeutics Inc is trending in the right direction. This prediction currently runs until 14.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Stoke Therapeutics Inc | 9.77% |
| iShares Core DAX® | -2.465% |
| iShares Nasdaq 100 | -2.812% |
| iShares Nikkei 225® | -0.345% |
| iShares S&P 500 | -2.640% |
Comments by BTIG_Research for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) had its price target raised by analysts at BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by BTIG_Research for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€15.60
18.08.25
18.08.25
€23.93
18.08.26
18.08.26
87.18%
16.10.25
16.10.25
